Back

Discussion: RELAX-REPEAT.

21 May 2016 (14:32 - 14:35)
Organised by:
Congress Presentation Part of: Late Breaking Trials I: Focus on acute heart failure Acute Heart Failure HFA Premium Access HEART FAILURE 2016

12 More presentations in this session

Presentation thumbnail
Bi treatment with hydralazine/nitrates versus placebo in africans admitted with acute heart failure (BA-HEF).
Professor K. Sliwa (Cape Town, ZA)
Presentation thumbnail
Discussion: BA-HEF.
Video
Presentation thumbnail
RELAX-REPEAT: a multicentre, prospective, randomised, double-blind study evaluating the safety and tolerability of repeat doses of serelaxin in patients with chronic heart failure.
Professor J. Teerlink (San Francisco, US)
Slides Video
Presentation thumbnail
Positive hemodynamic effects of CXL-1427, a novel nitroxyl prodrug in advanced heart failure patients.
Professor V. Mitrovic (Nauheim, DE)
Slides Video
Presentation thumbnail
Discussion: CXL-1427.
Video

Access the full session

Session thumbnail
Late Breaking Trials I: Focus on acute heart failure

The Event

Event poster

HEART FAILURE 2016

21 May 2016 14:32 CET
You may be interested in
thumbnail
Congress Presentation
RELAXIN-LA in worsening HFpEF
31 August 2025
thumbnail
ESC TV Today
Episode 5: Aortic aneurysms - Return to elite sports after a severe cardiac event
21 November 2024
thumbnail
Congress Presentation
The anti-arrhythmic properties of relaxin in heart failure with preserved ejection fraction
21 May 2023
thumbnail
Congress Presentation
Long-acting relaxin (LY3540378) demonstrates improved renal hemodynamics response in preclinical and clinical studies
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources